RSLS Historical PE Ratio image   This RSLS PE ratio history page last updated 11/15/2022
RSLS Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2022
11/14/2022
0.24-0.19-0.76NA
Q2 2022
8/15/2022
0.49-0.41-1.64NA
Q1 2022
5/23/2022
0.81-0.38-1.52NA
Q4 2021
3/28/2022
1.35-0.22-0.88NA
Q3 2021
11/11/2021
2.49-0.30-1.20NA
Q2 2021
8/5/2021
3.86-0.15-0.60NA
Q1 2021
5/17/2021
2.36-0.70-2.80NA
Q4 2020
3/10/2021
3.73-1.23-4.92NA
Q1 2020
5/14/2020
0.84-0.49-1.96NA
Q4 2019
3/26/2020
0.70-42.93-171.72NA
Q3 2019
11/14/2019
1.73-106.44-425.76NA
Q2 2019
8/14/2019
2.51-1.25-5.00NA
Q1 2019
5/20/2019
0.39-0.54-2.16NA
Q4 2018
4/1/2019
1.4710.3541.400.0
Q3 2018
11/14/2018
2.03-27.46-109.84NA
Q2 2018
8/14/2018
249.20-4.80-19.20NA
Q1 2018
5/14/2018
5922.00-0.36-1.44NA
Q4 2017
4/2/2018
7455.00-0.45-1.80NA
Q3 2017
11/14/2017
16527.00-0.59-2.36NA
Q2 2017
8/8/2017
18459.00-0.91-3.64NA
Q1 2017
5/16/2017
21147.00-1.27-5.08NA
Q4 2016
3/7/2017
19194.00-2.65-10.60NA
Q3 2016
11/10/2016
19425.00-0.17-0.68NA
Q2 2016
8/4/2016
NA-0.49-1.96NA
Q1 2016
5/5/2016
NA-0.94-3.76NA
Q4 2015
2/17/2016
NA-0.95-3.80NA
Q3 2015
11/9/2015
NA-0.04-0.16NA
Q2 2015
8/6/2015
NA-0.10-0.40NA
Q1 2015
4/30/2015
NA-0.10-0.40NA
Q4 2014
2/18/2015
NA-0.09-0.36NA
Q3 2014
11/12/2014
NA-0.08-0.32NA
Q2 2014
8/7/2014
NA-0.11-0.44NA
Q1 2014
4/30/2014
NA-0.10-0.40NA
Q3 2013
10/31/2013
NA-0.11-0.44NA
Q2 2013
7/31/2013
NA-0.11-0.44NA
Q1 2013
5/1/2013
NA-0.14-0.56NA
Q4 2012
2/13/2013
NA-0.17-0.68NA
Q2 2012
8/7/2012
NA-0.13-0.52NA
RSLS PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2022
11/14/2022
0.24-0.19-1.20NA
Q2 2022
8/15/2022
0.49-0.41-1.31NA
Q1 2022
5/23/2022
0.81-0.38-1.05NA
Q4 2021
3/28/2022
1.35-0.22-1.37NA
Q3 2021
11/11/2021
2.49-0.30-2.38NA
Q2 2021
8/5/2021
3.86-0.15-2.08NA
Q1 2021
5/17/2021
2.36-0.70-1.93NA
Q4 2020
3/10/2021
3.73-1.23-1.72NA
Q1 2020
5/14/2020
0.84-0.49-151.11NA
Q4 2019
3/26/2020
0.70-42.93-151.16NA
Q3 2019
11/14/2019
1.73-106.44-97.88NA
Q2 2019
8/14/2019
2.51-1.25-18.90NA
Q1 2019
5/20/2019
0.39-0.54-22.45NA
Q4 2018
4/1/2019
1.4710.35-22.27NA
Q3 2018
11/14/2018
2.03-27.46-33.07NA
Q2 2018
8/14/2018
249.20-4.80-6.20NA
Q1 2018
5/14/2018
5922.00-0.36-2.31NA
Q4 2017
4/2/2018
7455.00-0.45-3.22NA
Q3 2017
11/14/2017
16527.00-0.59-5.42NA
Q2 2017
8/8/2017
18459.00-0.91-5.00NA
Q1 2017
5/16/2017
21147.00-1.27-4.58NA
Q4 2016
3/7/2017
19194.00-2.65-4.25NA
Q3 2016
11/10/2016
19425.00-0.17-2.55NA
Q2 2016
8/4/2016
NA-0.49-2.42NA
Q1 2016
5/5/2016
NA-0.94-2.03NA
Q4 2015
2/17/2016
NA-0.95-1.19NA
Q3 2015
11/9/2015
NA-0.04-0.33NA
Q2 2015
8/6/2015
NA-0.10-0.37NA
Q1 2015
4/30/2015
NA-0.10-0.38NA
Q4 2014
2/18/2015
NA-0.09-0.38NA
Q3 2014
11/12/2014
NA-0.08-0.40NA
Q2 2014
8/7/2014
NA-0.11-0.43NA
Q1 2014
4/30/2014
NA-0.10-0.46NA
Q3 2013
10/31/2013
NA-0.11-0.53NA
Q2 2013
7/31/2013
NA-0.11-0.55NA
Q1 2013
5/1/2013
NA-0.14NANA
Q4 2012
2/13/2013
NA-0.17NANA
Q2 2012
8/7/2012
NA-0.13NANA
Quotes delayed 20 minutes

Email EnvelopeFree RSLS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Reshape Lifesciences (RSLS) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

RUBY PE Ratio History
RVMD PE Ratio History
RVNC PE Ratio History
RVPH PE Ratio History
RXDX PE Ratio History
RXRX PE Ratio History
RXST PE Ratio History
RYTM PE Ratio History
RZLT PE Ratio History
SAGE PE Ratio History
How should the RSLS historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Reshape Lifesciences. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this RSLS Historical PE Ratio page.

What is the average historical PE for RSLS based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The RSLS historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for RSLS based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The RSLS historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the RSLS Historical PE Ratio information for Reshape Lifesciences' stock. The average RSLS historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average RSLS historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this RSLS historical PE result, against the recent PE: when this page was posted on 11/14/2022, the most recent closing price for RSLS had been 0.24, and the most recent quarterly earnings result, annualized, was 41.4. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on RSLS or any other given stock, valuation analysis for RSLS can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Reshape Lifesciences PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RSLS. Thanks for visiting, and the next time you need to research RSLS Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: HCCC shares outstanding history, LEVL YTD Return, Top Ten Hedge Funds Holding CDMO.

 

RSLS Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.